Literature DB >> 1970737

Polysaccharides and membrane vaccines.

J T Poolman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970737

Source DB:  PubMed          Journal:  Adv Biotechnol Processes        ISSN: 0736-2293


× No keyword cloud information.
  8 in total

1.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 2.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

3.  Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Authors:  A F Verheul; A K Braat; J M Leenhouts; P Hoogerhout; J T Poolman; H Snippe; J Verhoef
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.

Authors:  X X Gu; C M Tsai
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.

Authors:  L G Milagres; S R Ramos; C T Sacchi; C E Melles; V S Vieira; H Sato; G S Brito; J C Moraes; C E Frasch
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  The membrane binding C-terminus of protein A from Staphylococcus aureus affects its cellular localization and causes structural deformation when expressed in Escherichia coli.

Authors:  A Warnes; M R Brown; A R Fooks; H Shuttleworth; A B Dowsett; J Melling; J R Stephenson
Journal:  Curr Microbiol       Date:  1993-06       Impact factor: 2.188

7.  Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.

Authors:  A F Verheul; J A Van Gaans; E J Wiertz; H Snippe; J Verhoef; J T Poolman
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis.

Authors:  R J Scholten; H A Bijlmer; H A Valkenburg; J Dankert
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.